Whole-Exome Sequencing Identifies MDH2 as a New Familial Paraganglioma Gene
Alberto Cascón(Spanish National Cancer Research Centre), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Miguel Urioste(Instituto de Salud Carlos III), María Currás-Freixes(Spanish National Cancer Research Centre), Andrés Pérez‐Barrios(Centro de Biología Molecular Severo Ochoa), Manel Esteller(Institució Catalana de Recerca i Estudis Avançats), Giovanna Roncador(Spanish National Cancer Research Centre), María Apellániz-Ruiz(Navarrabiomed), Aguirre A. de Cubas(Medical University of South Carolina), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Mirko Peitzsch(University Hospital Carl Gustav Carus), Javier Aller(Hospital Universitario Puerta de Hierro Majadahonda), Fernando Setién(Bellvitge University Hospital), Ana Rio‐Machín(Queen Mary University of London), Sharona Azriel(Hospital Universitario Infanta Sofía), Sebastián Morán(Institut d'Investigació Biomédica de Bellvitge), Laura Contreras(Centro de Biología Molecular Severo Ochoa), Álvaro Gómez-Graña(Spanish National Cancer Research Centre), Juan F. Garcı́a(MD Anderson Cancer Center Madrid), Veronika Mančíková(Centro de Biología Molecular Severo Ochoa), Lucía Inglada‐Pérez(Spanish National Cancer Research Centre), María Calatayud(Hospital Universitario 12 De Octubre), Susan Richter(University of Auckland), Iñaki Comino‐Méndez(Breast Cancer Now), Rocío Letón, Rosa Villar-Vicente(Centro de Biología Molecular Severo Ochoa), Jorgina Satrústegui(Universidad Autónoma de Madrid)
Cited by 189
Related Papers
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
Inactivation of the DNA-Repair Gene<i>MGMT</i>and the Clinical Response of Gliomas to Alkylating Agents
|New England Journal of Medicine|2000|2.2k
The role of histone deacetylases (HDACs) in human cancer
|Molecular Oncology|2007|984
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791